1
2
Therapeutic activity of agonistic, human anti-CD40 monoclonal Abs requires selective FcγR-engagement
Por Dahan, Rony, Barnhart, Bryan C., Li, Fubin, Yamniuk, Aaron P., Korman, Alan, Ravetch, Jeffrey V.
Publicado no Cancer Cell (2016)
Obter o texto integralPublicado no Cancer Cell (2016)
Obter o texto integral
Obter o texto integral
Artigo
3
4
5
Por Vandenbark, Arthur A., Meza-Romero, Roberto, Benedek, Gil, Andrew, Shayne, Huan, Jianya, Chou, Yuan K., Buenafe, Abigail C., Dahan, Rony, Reiter, Yoram, Mooney, Jeffery L., Offner, Halina, Burrows, Gregory G.
Publicado em 2012
Obter o texto integralPublicado em 2012
Obter o texto integral
Obter o texto integral
Artigo
6
Por Arce Vargas, Frederick, Furness, Andrew J.S., Solomon, Isabelle, Joshi, Kroopa, Mekkaoui, Leila, Lesko, Marta H., Miranda Rota, Enrique, Dahan, Rony, Georgiou, Andrew, Sledzinska, Anna, Ben Aissa, Assma, Franz, Dafne, Werner Sunderland, Mariana, Wong, Yien Ning Sophia, Henry, Jake Y., O’Brien, Tim, Nicol, David, Challacombe, Ben, Beers, Stephen A., Turajlic, Samra, Gore, Martin, Larkin, James, Swanton, Charles, Chester, Kerry A., Pule, Martin, Ravetch, Jeffrey V., Marafioti, Teresa, Peggs, Karl S., Quezada, Sergio A.
Publicado no Immunity (2017)
Obter o texto integralPublicado no Immunity (2017)
Obter o texto integral
Obter o texto integral
Artigo